en · de · es · pt
cjc-1295-notes.peptides6155.com › Blog › Handling Storage And Analytical Methods — Hands-On Walkthrough

Handling Storage And Analytical Methods — Hands-On Walkthrough

By Editorial Desk · published 2026-01-12 · last reviewed 2026-02-03 · Blog

If you have been reading about drug affinity complex and want a single page that covers the useful parts, this is it: definitions, context, how it is studied, and the questions that come up repeatedly.

Updated 2026-02-03. Numbers and descriptions here follow the published literature rather than marketing material.

Handling Storage And Analytical Methods

Purity is most often assessed by reversed-phase high-performance liquid chromatography, reported as a percentage of total peak area. Identity is confirmed by mass spectrometry, which yields a molecular ion consistent with the expected sequence. Amino acid analysis and peptide mapping provide additional characterization. Reported purity values are method-dependent, so figures from different laboratories are not always directly comparable without details of column, gradient, and detection wavelength.

Peptide degradation proceeds mainly through hydrolysis, oxidation of methionine, and deamidation of asparagine or glutamine residues. The maleimide group on the albumin-binding variant can also react with thiols or hydrolyze in aqueous media. Because these pathways accelerate with temperature and pH extremes, handling conditions strongly influence measured stability. Stability data in the public literature are limited and often generated under differing conditions, so general statements about shelf life should be read as approximate.

Molecular Background and Naming

Two related forms circulate in technical discussion under the same family name. The original version carries a drug affinity complex (DAC) that binds covalently to serum albumin after administration, and this linkage substantially extends circulation time. A second form, frequently written as modified GRF(1-29) or CJC-1295 without DAC, lacks that linker and clears much faster. The naming is a frequent source of confusion because the shorthand CJC-1295 can refer to either form depending on the source. Reports sometimes fail to specify which variant was studied.

The peptide backbone includes a D-alanine at position two, which resists cleavage by dipeptidyl peptidase IV, and several other substitutions that reduce degradation. Its molecular weight is roughly 3.4 kDa without the linker and about 3.6 kDa with it. The molecule is water soluble and is normally supplied as a lyophilized powder. Precise sequence and mass values depend on which variant is described, so technical documents usually state the exact form being referenced.

Cjc-1295 at a glance

PropertyValueNotes
AppearanceWhite to off-white lyophilized powderVisual descriptor; not a measure of purity
Solubility classFreely soluble in waterAqueous dissolution may require gentle mixing
Typical storage (powder)−20 °C or below, desiccatedProtect from light and ambient moisture
Typical storage (solution)2–8 °C, short termFreeze aliquots where longer holding is needed
Purity assessmentReversed-phase HPLC, area percentValues depend on column, gradient, and detection wavelength

Background and Molecular Features

CJC-1295 is a synthetic peptide modeled on growth hormone-releasing hormone, the hypothalamic signal that prompts the pituitary to release growth hormone. Its sequence corresponds to the first twenty-nine residues of human GHRH, with four substitutions that slow enzymatic breakdown. Early descriptions placed the compound in research on growth hormone deficiency and related conditions, and later literature groups it with the long-acting GHRH analogs. The name appears in both laboratory and popular fitness writing, where it sometimes labels chemically different peptides.

Two related peptides circulate under the CJC-1295 label, and they differ mainly in how long they persist in circulation. The version carrying a drug affinity complex includes a maleimidopropionic acid linker that forms a covalent bond with serum albumin. The other version, usually written as modified GRF(1-29) or tetrasubstituted GRF(1-29), lacks that linker and is cleared quickly. Mixing the two produces inconsistent readings of published half-life values, because the linker rather than the receptor-facing sequence drives most of the difference.

Related pages on this site

Background and Molecular Design

Two forms circulate under the CJC-1295 name, and they differ by a single appended group. The version without a drug affinity complex carries four substitutions along the peptide chain, including a D-alanine near the amino terminus and replacements at three other positions. These changes block the enzyme dipeptidyl peptidase IV and remove a methionine residue that is prone to oxidation. The modified fragment is frequently labeled MOD GRF 1-29. Naming conventions are inconsistent across informal sources, which is a common source of confusion.

The second form adds a maleimide-bearing linker to the lysine at the carboxyl end. This group reacts with cysteine-34 on circulating serum albumin, forming a covalent bond that keeps the peptide in the bloodstream for far longer. ConjuChem developed the molecule as a way to extend the action of a peptide without frequent administration. The albumin attachment is the defining structural feature of the drug affinity complex version. Whether continuous exposure produces effects distinct from shorter pulses remains an unresolved research question.

Background and Naming Conventions

The dividing feature between the two forms is a maleimide-based drug affinity complex, abbreviated DAC. In the DAC-bearing version, a linker attaches the peptide to serum albumin after administration, and that association slows removal from plasma. The version lacking DAC appears in catalogs as MOD GRF(1-29) or tetrasubstituted GRF(1-29). Because informal writing treats both as one item, comparisons drawn from such sources routinely blend measurements taken from two molecules with substantially different behavior.

Four amino acid substitutions separate the modified backbone from the parent GRF(1-29) sequence. These changes reduce recognition by dipeptidyl peptidase IV and related proteases, extending the interval before degradation. Development work in this area sought longer-acting GHRH analogs for endocrine investigation. Published descriptions treat the substitution set as a defining property of the core sequence, while the albumin-binding linker is described separately as an optional addition to that same backbone.

Mechanism and Pharmacokinetics

Studies in this area generally track growth hormone pulses, insulin-like growth factor 1 concentrations, and occasionally body composition endpoints. Most published human data come from early, small trials, and questions about long-term effects remain open. Whether repeated exposure alters pituitary responsiveness over time is not settled. Analytical work relies on immunoassays for the hormones and on mass spectrometry for the peptide itself, because the two measurements answer different questions.

Binding of the peptide to the growth hormone-releasing hormone receptor on pituitary somatotrophs triggers a G protein coupled cascade that raises cyclic AMP and opens calcium channels. The result is greater secretion of growth hormone into the bloodstream. Because the peptide acts at the same receptor as the natural hypothalamic hormone, its effect is amplified pulse size rather than an entirely separate release pathway. Receptor binding alone does not determine the response, since somatostatin tone and other inputs modulate the final output.

The albumin-binding version stays in circulation for days, because covalent attachment to serum albumin shields the peptide from rapid filtration and degradation. Reported half-lives for this form fall in the range of several days. The version without the linker is cleared in minutes, with estimates often near thirty minutes in animal work. These figures come from small studies and vary with assay method, species, and route, so they are best read as approximate rather than fixed constants.

Background from the literature

Many different foods can be prepared by dehydration. Meat has held a historically significant role. For centuries, much of the European diet depended on dried cod—known as salt cod, bacalhau (with salt), or stockfish (without). It formed the main protein source for the slaves on the West Indian plantations, and was a major economic force within the triangular trade. Dried fish most commonly cod or haddock, known as Harðfiskur, is a delicacy in Iceland, while dried reindeer meat is a traditional Sámi food. Dried meats include prosciutto (Parma ham), bresaola, biltong and beef jerky. Dried fruits have been consumed historically due to their high sugar content and sweet taste, and a longer shelf-life from drying. Fruits may be used and named differently when dried. The plum becomes a prune, the grape a raisin. Figs and dates may be transformed into different products that can either be eaten as they are, used in recipes, or rehydrated. Freeze-dried vegetables are often found in food for backpackers, hunters, and the military. Garlic and onion are often dried and stored with their stalks braided. Edible mushrooms are sometimes dried for preservation or to be used as seasonings.

=== Taxonomic diversity === The most recent estimate (as of January 2024) documents 50,605 living and 10,556 fossil algal species, according to the online database AlgaeBase. They are classified into 15 phyla or divisions. Some phyla are not photosynthetic, namely Picophyta and Rhodelphidophyta, but they are included in the database due to their close relationship with red algae.

=== Cookbooks === American Gastronomy: An Illustrated Portfolio of Recipes and Culinary history (1974), ISBN 978-0809283415 The Bakery Restaurant Cookbook (1980), ISBN 978-0843621952 The Chef's New Secret Cookbook (1975), ISBN 978-0809283545 The Chef's Secret Cook Book: A Practical, Personal Invitation to Classic Cookery (1971), ISBN 978-0812902136 Sears Gourmet Cooking Forum (1969)

Any individual member of the clinical trial team designated and supervised by the investigator at a trial site to perform critical trial-related procedures and/or to make important trial-related decisions (e.g., associates, residents, research fellows). (ICH E6) Subject Identification Code

Sources: en.wikipedia.org

Further detail

Isaria cicadae Miq. 1838, which is the same as Cordyceps cicadae (Miq.) Massee 1895 and Paecilomyces cicadae. The preferred name for this species appears to be Cordyceps cicadae (Miq.) Massee 1895, especially since Isaria has proven to be polyphyletic. Cordyceps cicadae Shing 1975, which is now properly known as Tolypocladium dujiaolongae Y.P. Cao & C.R. Li after its local name in TCM ("Du Jiao Long"). Some Chinese sources believe that it is the teleomorph of "Chan Hua", which is now proven false with the discovery of its true teleomorph. Cordyceps sobolifera (now Ophiocordyceps sobolifera). Japanese sources incorrectly believe that this is the teleomorph of "Chan Hua", but it is in reality another TCM material known as "Xiao Chan Hua" (small cicada flower). The error has spread to Korean, Taiwanese, and Chinese sources. Cordyceps kobayasii, another purported teleomorph of "Chan Hua". Cordyceps chanhua Z.Z. Li et al., which is the correct name of "Chan Hua". In traditional medicine-related papers, each of the names have been used to describe the material known as "Chan Hua". C. cicadae and I. cicadae used to be very common in sources written by Chinese researchers, though they have largely adopted the corrected C. chanhua name. Japanese, Korean, and Taiwanese sources still use C. sobolifera. Other reported synonyms include Cordyceps zhejiangensis and C. sinclairii.

annealing The hybridization of two single-stranded nucleic acid molecules containing complementary sequences, creating a double-stranded molecule with paired nucleobases. The term is used in particular to describe steps in laboratory techniques such as polymerase chain reaction, where double-stranded DNA molecules are repeatedly denatured into single strands by heating and then exposed to cooler temperatures, causing the strands to reassociate with each other or with complementary primers. The exact temperature at which annealing occurs is strongly influenced by the length and specific sequence of the individual strands.

In biology, a mutation is an alteration in the nucleic acid sequence of the genome of an organism, virus, or extrachromosomal DNA. Mutations result from errors during replication, mitosis, meiosis, or damage to DNA, which then may trigger error-prone repair or cause an error during replication (translesion synthesis). Mutations may also result from substitution, insertion or deletion of segments of DNA due to mobile genetic elements.

Sources: en.wikipedia.org

Frequently asked questions

How should the dry powder be stored?

Cool, dark, and dry conditions are standard, with storage at minus twenty degrees Celsius or below. Desiccant and sealed vials limit moisture uptake. Repeated warming and cooling of the container is generally avoided.

Does a solution need to be used immediately?

There is no single agreed limit, and laboratory practice varies widely. Refrigeration slows degradation, and freezing aliquots is often described for longer holding. Any visible cloudiness or precipitate indicates the solution should be discarded.

Which analytical methods confirm identity?

Mass spectrometry provides the most direct confirmation through molecular mass. Reversed-phase chromatography supports purity assessment, and peptide mapping or amino acid analysis can corroborate sequence. No single method establishes both purity and identity on its own.

Is CJC-1295 a natural hormone?

No. It is a synthetic analogue modeled on the first 29 residues of human GHRH. The substitutions and any linker are laboratory modifications rather than features of the endogenous peptide.

Network